Session I: September 8, 2021
The Impact of COVID-19 On The Prostate Cancer Racial Disparity
COVID-19 delayed prostate cancer early detection screening and treatments. It also ushered in an increased use of telemedicine for prostate cancer care which is anticipated to expand and become more of a standard of care. This session assesd the impact of the pandemic, with a focus on how the increased use of telemedicine will impact the prostate cancer racial disparity based on the experiences and perspectives of doctors and patients.
Prior Summit Images
Welcome and Opening Remarks: Mr. Thomas Farrington, President and Founder, PHEN
Remarks: Congressman Gregory W. Meeks (D5-NY) Watch Video
Moderator: Edith Mitchell, MD, MACP, FCPP, FRCP, Clinical Professor of Medicine and Medical Oncology; Department of Medical Oncology, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs, Sidney Kimmel Cancer Center at Jefferson
The COVID-19 Pandemic and Increased Telemedicine Use for Prostate Cancer: Daniela Wittman, PhD, LMSW, Clinical Professor of Medicine, University of Michigan Watch Video
PHEN Survey Results of Black Patients’ experiences and perspectives on Telemedicine: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN Watch Video
- Robert Waterhouse Jr., MD, Urologist, Carolinas Medical Center
- J. Jacques Carter, MD, MPH, Professor of Medicine, Harvard Medical School
- Mr. Derrick Butts, Survivor / Author
- Mr. Azell Martin, Survivor
- Mr. Jimmy Barnes, Survivor
Session One Recording:
Session Participants
Mr. Thomas Farrington
Congressman Gregory Meeks
Edith Mitchell, MD, MACP, FCPP, FRCP
Daniela Wittman, PhD, LMSW
Keith Crawford, MD, PhD
Robert Waterhouse, Jr., MD
J. Jacques Carter, MD
Mr. Derrick Butts
